DNMT3A
Gene Ontology | |
---|---|
Molecular function | • DNA binding • chromatin binding • DNA (cytosine-5-)-methyltransferase activity • protein binding • unmethylated CpG binding • metal ion binding • DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates |
Cellular component | • chromosome, centromeric region • euchromatin • nucleus • nuclear heterochromatin • nucleolus • cytoplasm • nuclear matrix |
Biological process | • negative regulation of transcription from RNA polymerase II promoter • DNA methylation • methylation-dependent chromatin silencing • regulation of gene expression by genetic imprinting • spermatogenesis • DNA methylation on cytosine within a CG sequence • DNA methylation involved in embryo development • DNA methylation involved in gamete generation • hypermethylation of CpG island • S-adenosylhomocysteine metabolic process • S-adenosylmethioninamine metabolic process • cellular response to amino acid stimulus |
Sources: Amigo / QuickGO |
25.46 – 25.57 Mb
3.81 – 3.91 Mb
DNA (cytosine-5)-methyltransferase 3A is an enzyme that in humans is encoded by the DNMT3A gene.
CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than the maintenance of existing methylated sites. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated. Alternative splicing results in multiple transcript variants encoding different isoforms.
Read more about DNMT3A: Clinical Relevance, Interactions